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Interactions of Asbestos*Activated
Macrophages with an Experimental
Fibrosarcoma
by K. Donaldson,* J. M. G. Davis,* A. Ewingt
and K. Jamest
Supernatants from in vivo asbestos-activated macrophages failed to show any cytostatic activity
against a syngeneic fibrosarcoma cell line in vitro. UICC chrysotile-induced peritoneal exudate
cells also failed to demonstrate any growth inhibitory effect on the same cells in Winn assays of tu-
mor growth. Mixing UICC crocidolite with inoculated tumor cells resulted in a dose-dependent inhi-
bition of tumor growth; this could, however, be explained by a direct cytostatic effect on the tumor
cells of high doses of crocidolite, which was observed in vitro.
Introduction
Recently there has been an accumulation of ex-
perimental evidence suggesting that asbestos can
have a stimulatory or activating effect on macro-
phages in vivo and in vitro. Davies et al. (1) reported
that peritoneal macrophages treated with asbestos
in vitro released lysosomal hydrolases without evi-
dence of cell death, and Hamilton and co-workers (2,
3) demonstrated that asbestos in vivo and in vitro
induces selective release of the neutral protease
plasminogen activator from peritoneal macro-
phages. Humes et al. (4) and Sirois (5) have reported
the induction of prostaglandin release by peritoneal
and alveolar macrophages treated with asbestos in
vitro. Selective release of lysosomal hydrolases and
neutral proteases from macrophages can be induced
by a range of macrophage activating agents, both
immunological and nonimmunological (6).
Miller and Kagan (7) have reported that the alve-
olar macrophages of rats inhaling crocidolite show
evidence of activation by morphology, Fc receptor
avidity and the ability to stimulate T-lymphocytes
to take up thymidine. We have studied the macro-
phages induced in the peritoneal cavity by intra-
peritoneal asbestos injection and have found maco-
phages to be activated by several criteria (8, 9) but
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full activation to the tumor cell cytotoxic state was
not found (8). Small significant reductions in the size
of experimental subcutaneous fibrosarcomas were,
however, found in mice which had received UICC
chrysotile intraperitoneally compared with mice
which had received saline intraperitoneally.
In this paper we present further studies into the
interactions of asbestos, macrophages and an ex-
perimental fibrosarcoma.
Materials and Methods
Macrophage Plasma Membrane
5'-Nucleotidase and Lysosomal Acid
Phosphatase
These assays were carried out according to the
method of Raz et al. (10) using glycerophosphate
(Sigma) and 5'-adenosine monophosphate (Sigma) as
substrates, and assaying for phosphate release by
the method of Ames and Dubin (11). Protein was as-
sayed by the method of Lowry (12).
Experimental Fibrosarcoma
The experimental tumor line used was the CCH,
fibrosarcoma derived from a subcutaneous methyl-
cholanthrene-induced fibrosarcoma in CBA/Ca mice.
It has been maintained in long-term culture and pas-
saged through mice at intervals (13).
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Macrophage Supernatants, Leachate and
Asbestos
Peritoneal exudate cells (PEC) were harvested 3
days after intraperitoneal injection of UICC crocido-
lite, chrysotile, latex spheres (0.81 pm diameter, Dif-
co) or saline. The macrophages were maintained in
culture over 24 hr in complete RPMI (RPMI 1640,
Gibco) containing 10% fetal calf serum (Gibco) and
antibiotics (cRPMI). The supernatant was centri-
fuged, aliquoted and stored frozen at - 200C until
use. Leachate was prepared by incubating crocido-
lite or chrysotile (5 mg/mL) in cRPMI for 3 days at
370C then spinning out the fiber by centrifuging at
3500g for 1 hr. Asbestos was serum-coated to re-
duce direct cytotoxic effects by preincubating for 1
hr at 370C in cRPMI.
CCH1 Tumor Cell Proliferation Assay
The same assay system was used to measure the
effect of macrophage supernatants, asbestos or as-
bestos leachate on CCHI cell proliferation in vitro.
5 x 104 CCH, cells were inoculated into microtiter
plates (Sterilin) in 100 ML of cRPMI. Various vol-
umes of supernatant, leachate or asbestos (preincu-
bated in cRPMI for 1 hr at 370C) were then added,
and the final volume was adjusted to 200,L with
cRPMI. After 24 hr, 0.25 ,ACi of 3H-thymidine were
added to each well and after a further 24 hr the
cells were harvested in a cell harvester (Skatron);
cell-bound 3H-thymidine counts were measured by
liquid scintillometry.
Winn Assay
The assay used was essentially the same as that
described by Gabizon and Trainin (14). PECs ob-
tained 3 days after IP injection of saline or chryso-
tile (5 mg) were harvested, counted and mixed with
CCH, tumor cells in the following ratios: (1) 10:1, i.e.,
105 CCH, cells plus 106 PEC in 0.1 mL Dulbecco's
phosphate buffered saline (Dul. A) and (2) 100:1, i.e.,
5 x 101 CCH, cells plus 5 x 104 PEC in 0.1 mL Dul
A. Groups of 10 mice received 0.1 mL subcutane-
ously in the right hind limb. Tumor growth was
monitored by taking the mean of the two major di-
ameters of the tumor.
Table 1. Plasma membrane 5'-nucleotidase and
lysosomal acid phosphatase activity in 3-day saline-
and 3-day chrysotile-induced macrophages.
5'-Nucleotidase, Acid phosphatase
*mole phosphate! *mole phosphate/
Macrophage source mg protein/hr mg protein/hr
Saline-induced
(3-day) 3.7 0.4
Chrysotile-induced
(3-day) 0.5 4.7
Chrysotile was arbitrarily chosen for this assay
since previous studies (8) had shown crocidolite and
chrysotile to be similar in their ability to activate
macrophages.
Inclusion of Crocidolite in Tumor Cell
Inoculum
UICC crocidolite was incubated in normal mouse
serum for 1 hr at 370C and then mixed with CCH,
cells so that 0.1 mL of inoculum contained 10 ,L of
normal mouse serum; 0, 5, 50, or 500 lAg of crocido-
lite; and 5 x 102 CCH, cells. Groups of 10 mice re-
ceived 0.1 mL subcutaneously in the right hind limb
and tumor growth was monitored.
Statistical Analysis
All differences were examined for statistical sig-
nificance using Student's t-test.
Results
Table 1 shows that chrysotile-induced macro-
phageshave decreased plasma membrane 5'-nucleo-
tidase and increased acid phosphatase content, com-
pared to saline-induced macrophages.
The effect of 24-hr supernatants of macrophages
induced by various agents on tumor cell prolifera-
tion is shown in Figure 1. Statistical analysis re-
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FIGURE 1. Effect of supernatants from 3-day saline-, latex-,
crocidolite- or chrysotile-induced peritoneal exudate macro-
phages on proliferation of tumor cells in vitro as measured by
3H-thymidine uptake.
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vealed no significant effects of macrophage super-
natants from any source, on CCH1 cell proliferation,
compared to CCH, cells alone. There was consider-
able variation in the response of CCH1 cells to these
supernatants between experiments, and this is re-
flected in the large amount of variation evident in
Figure 1, which represents the mean and standard
errors of five separate experiments.
Although there were differences in the mean tu-
mor diameter produced by tumor cells alone, tumor
cells mixed with saline-induced PEC and tumor cells
mixed with chrysotile-induced PEC, at both 10:1
and 100:1 (Figs. 2 and 3), these differences were not
statistically significant.
Figure 4 shows a dose-dependent inhibition of tu-
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FIGURE 2. Effect of 3-day saline- and 3-day chrysotile-induced
peritoneal exudate cells on subcutaneous tumor growth in a
Winn assay; peritoneal exudate cell: tumor cell ratio of 10:1 at
subcutaneous inoculation. Although no positively cytostatic
Winn assay control was included in these experiments, in-
traperitoneal C. parvum is known to inhibit this tumor model
by inducing tumor cell cytotoxic macrophages (8).
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FIGURE 3. Effect of 3-day saline- and 3-day chrysotile-induced
peritoneal exudate cells on tumor growth in a Winn assay;
peritoneal exudate cell:tumor cell ratio of 100:1 at subcutane-
ous injection.
mor growth produced by mixing crocidolite that
had been preincubated with normal mouse serum
with the CCH1 tumor cell inoculum.
The effects of crocidolite and chrysotile, at doses
which extend over four orders of magnitude, on pro-
liferation of CCH, tumor cells in vitro are shown in
Figure 5; remarkably little effect is seen except at
the very highest doses of asbestos, where crocido-
lite caused marked inhibition of 3H-thymidine up-
take by tumor cells. Figure 5 also shows that croci-
dolite leachate, at the highest concentration, pro-
duced inhibition of 3H-thymidine uptake.
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FIGURE 4. Effect of tumor growth of 0, 5, 50 or 500 Mg of cro-
cidolite percent along with tumor cells at subcutaneous inocu-
lation.
%LEACHATE
FIGURE 5. Effect of various doses of asbestos and asbestos
leachate on tumor cell proliferation in vitro.
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Discussion
In this paper we describe experiments which
were aimed at further elucidating the degree of ac-
tivation of macrophages induced in the murine peri-
toneal cavity by injection of asbestos.
Macrophage activation apparently involves the
sequential adoption of properties which can culmi-
nate in the fully tumoricidal state (15). In keeping
with other reports, we have found that asbestos,
can lead to activation of macrophages in vivo but,
using an in vitro assay, we failed to detect any evi-
dence of tumor cell cytotoxicity by asbestos-acti-
vated macrophages although Corynebacterium par-
vum-activated macrophages were tumoricidal in
this system (8). However, in the same study, there
was the contradictory finding in vivo that the ad-
ministration of asbestos by intraperitoneal injection
to mice caused a small but significant reduction in
the growth of an experimental subcutaneous tumor.
The present study follows on from this work and
examines whether the tumor-retarding effect that
was noted in vivo could be associated with macro-
phage activation.
Macrophage cytostatic activity, as well as cyto-
toxic activity, can play a role in retarding tumor
growth, and this can be mediated by soluble factors
(16). The supernatants from asbestos-activated mac-
rophages were therefore tested in an assay of CCH,
tumor cell proliferation in vitro. No significant in-
hibitory activity against tumor cell proliferation
was detected in crocidolite, chrysotile, latex or sa-
line-induced macrophage supernatants using Stu-
dent's t-test.
In a further attempt to detect cytostatic activity
in asbestos-activated macrophages, and in an effort
to circumvent the problem produced by difference
between the site of the tumor (leg) and the site of
primary macrophage activation (the peritoneal cav-
ity), two approaches were tried. In the first ap-
proach, Winn assays were used to bring 3-day as-
bestos- or saline-induced PEC into close contact
with the target tumor cells by mixing them to-
gether at various effector: target ratios; this mix-
ture was then inoculated and tumor growth com-
pared to that of tumors produced with the appropri-
ate number of tumor cells alone and with similar ef-
fector: target ratios of saline-induced PEC and
tumor cells. No significant differences in tumor size
were obtained with chrysotile-activated macro-
phages at ratios of either 10:1 or 100:1 compared to
controls, and therefore no evidence of tumor cell
cytostatic activity in asbestos-activated macro-
phages was detected.
In a second approach various doses of crocidolite
asbestos that had been preincubated in serum-con-
taining medium for 1 hr were mixed with inocu-
lating tumor cells and tumor growth monitored. The
dose-dependent decrease in tumor size which was
obtained could have been due to local macrophage
activation to the cytostatic state or could have been
due to a direct toxic effect of crocidolite on the tu-
mor cells. It was specifically to avoid such a direct
toxic effect that crocidolite was chosen rather than
chrysotile, since the amphiboles have a less active
surface than chrysotile, and this is also why the cro-
cidolite was precoated by incubation in serum-con-
taining medium. However, in order to test for such
a direct toxic effect of crocidolite on tumor cells,
crocidolite was used in the in vitro CCH1 cell prolif-
eration assay. It was clear that both chrysotile and
crocidolite and a fiber-free leachate of both asbestos
types produced very little effect at all doses, except
for inhibition at the highest doses with crocidolite.
Since the doses of crocidolite present in inocula
compared closely with, or exceeded, the doses used
in the in vitro assay, it is evident that the reduction
of tumor size produced could be accounted for by di-
rect toxic effects of crocidolite on CCH, tumor cells.
The induction of local tumor cell cytostatic macro-
phages does not therefore have to be evoked as a
mechanism.
It seems likely that the small but significant re-
duction in the size of experimental tumors in mice
injected with chrysotile which we reported pre-
viously (8) was not macrophage-mediated and that
the overall adjuvant effect of asbestos could result
in a nonspecific mobilization of some of the other
well-documented antitumor immune responses.
The tumoricidal potential of macrophages has
been used in these studies in the context of assess-
ing the degree of macrophage activation and the re-
sults suggest that asbestos-activated macrophages
have not attained the fully activated tumoricidal
state. Tumor cell cytotoxic macrophages have been
considered to be part of the surveillance system
which acts to eliminate transformed cells before tu-
mors can develop, and so the potential of asbestos-
activated macrophages to attain full tumoricidal sta-
tus has relevance for asbestos carcinogenesis. Pre-
vious studies have produced evidence that asbestos
can act as a tumor promoter in classical two-stage
carcinogenesis after initiation by polycyclic hydro-
carbons (17, 18). A recent report has shown that a
tumor promoter can block lymphokine-mediated ac-
tivation of macrophages to the tumoricidal state
(19). If this is shown to be a general property of tu-
mor promoters, then it could be of particular rele-
vance to asbestos carcinogenesis.
The authors would like to acknowledge the financial sup-
port of the Asbestosis Research Council (KD, JMGD) and the
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